The pro-angiogenic activity of urotensin-II on human vascular endothelial cells involves ERK1/2 and PI3K signaling pathways

Diego Guidolin, Giovanna Albertin, Barbara Oselladore, Elisa Sorato, Piera Rebuffat, Alessandra Mascarin, Domenico Ribatti

Research output: Contribution to journalArticle

Abstract

Human vascular endothelial cells express the urotensin-II (U-II) receptor and exhibit a strong in vitro angiogenic response to the peptide. Thus, in the present study an in vitro model, based on human umbilical vein endothelial cells (HUVEC) cultured on Matrigel, was used to characterize more in detail the signaling pathways that control the pro-angiogenic action of U-II. The activation of the U-II receptor (UT) was associated with an increase of intracellular calcium concentration. Both calcium rise and pro-angiogenic effect of the peptide can be blocked by U73122, a selective inhibitor of phospholipase-C, indicating that the signal transduction from UT mainly involves the phospholipase-C/IP3 pathway. As far as the downstream signaling pathways are concerned, western blot analyses and experiments with specific inhibitors indicated that the U-II-induced self-organization of the cells into capillary-like structures was PKC dependent and involved the activation of the ERK1/2, but not p38-MAPK, transduction pathway. Interestingly, the pharmacological inhibition of PI3K (obtained with LY294002), hindered the capacity of U-II to induce a proangiogenic effect on HUVEC, suggesting that PI3K-dependent pathways also play a role in regulating the process.

Original languageEnglish
Pages (from-to)26-32
Number of pages7
JournalRegulatory Peptides
Volume162
Issue number1-3
DOIs
Publication statusPublished - Jun 2010

Fingerprint

Endothelial cells
Phosphatidylinositol 3-Kinases
Endothelial Cells
Human Umbilical Vein Endothelial Cells
Type C Phospholipases
Angiogenic Proteins
Chemical activation
Calcium
Signal transduction
Peptides
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one
p38 Mitogen-Activated Protein Kinases
Signal Transduction
Western Blotting
urotensin II
Pharmacology
Experiments
In Vitro Techniques

Keywords

  • Angiogenesis
  • Human endothelial cells
  • Signaling pathways
  • Urotensin-II

ASJC Scopus subject areas

  • Biochemistry
  • Clinical Biochemistry
  • Endocrinology
  • Physiology
  • Cellular and Molecular Neuroscience

Cite this

Guidolin, D., Albertin, G., Oselladore, B., Sorato, E., Rebuffat, P., Mascarin, A., & Ribatti, D. (2010). The pro-angiogenic activity of urotensin-II on human vascular endothelial cells involves ERK1/2 and PI3K signaling pathways. Regulatory Peptides, 162(1-3), 26-32. https://doi.org/10.1016/j.regpep.2010.02.009

The pro-angiogenic activity of urotensin-II on human vascular endothelial cells involves ERK1/2 and PI3K signaling pathways. / Guidolin, Diego; Albertin, Giovanna; Oselladore, Barbara; Sorato, Elisa; Rebuffat, Piera; Mascarin, Alessandra; Ribatti, Domenico.

In: Regulatory Peptides, Vol. 162, No. 1-3, 06.2010, p. 26-32.

Research output: Contribution to journalArticle

Guidolin, D, Albertin, G, Oselladore, B, Sorato, E, Rebuffat, P, Mascarin, A & Ribatti, D 2010, 'The pro-angiogenic activity of urotensin-II on human vascular endothelial cells involves ERK1/2 and PI3K signaling pathways', Regulatory Peptides, vol. 162, no. 1-3, pp. 26-32. https://doi.org/10.1016/j.regpep.2010.02.009
Guidolin, Diego ; Albertin, Giovanna ; Oselladore, Barbara ; Sorato, Elisa ; Rebuffat, Piera ; Mascarin, Alessandra ; Ribatti, Domenico. / The pro-angiogenic activity of urotensin-II on human vascular endothelial cells involves ERK1/2 and PI3K signaling pathways. In: Regulatory Peptides. 2010 ; Vol. 162, No. 1-3. pp. 26-32.
@article{3e4507ff97ad4d858e6be86f8543432a,
title = "The pro-angiogenic activity of urotensin-II on human vascular endothelial cells involves ERK1/2 and PI3K signaling pathways",
abstract = "Human vascular endothelial cells express the urotensin-II (U-II) receptor and exhibit a strong in vitro angiogenic response to the peptide. Thus, in the present study an in vitro model, based on human umbilical vein endothelial cells (HUVEC) cultured on Matrigel, was used to characterize more in detail the signaling pathways that control the pro-angiogenic action of U-II. The activation of the U-II receptor (UT) was associated with an increase of intracellular calcium concentration. Both calcium rise and pro-angiogenic effect of the peptide can be blocked by U73122, a selective inhibitor of phospholipase-C, indicating that the signal transduction from UT mainly involves the phospholipase-C/IP3 pathway. As far as the downstream signaling pathways are concerned, western blot analyses and experiments with specific inhibitors indicated that the U-II-induced self-organization of the cells into capillary-like structures was PKC dependent and involved the activation of the ERK1/2, but not p38-MAPK, transduction pathway. Interestingly, the pharmacological inhibition of PI3K (obtained with LY294002), hindered the capacity of U-II to induce a proangiogenic effect on HUVEC, suggesting that PI3K-dependent pathways also play a role in regulating the process.",
keywords = "Angiogenesis, Human endothelial cells, Signaling pathways, Urotensin-II",
author = "Diego Guidolin and Giovanna Albertin and Barbara Oselladore and Elisa Sorato and Piera Rebuffat and Alessandra Mascarin and Domenico Ribatti",
year = "2010",
month = "6",
doi = "10.1016/j.regpep.2010.02.009",
language = "English",
volume = "162",
pages = "26--32",
journal = "Regulatory Peptides",
issn = "0167-0115",
publisher = "Elsevier",
number = "1-3",

}

TY - JOUR

T1 - The pro-angiogenic activity of urotensin-II on human vascular endothelial cells involves ERK1/2 and PI3K signaling pathways

AU - Guidolin, Diego

AU - Albertin, Giovanna

AU - Oselladore, Barbara

AU - Sorato, Elisa

AU - Rebuffat, Piera

AU - Mascarin, Alessandra

AU - Ribatti, Domenico

PY - 2010/6

Y1 - 2010/6

N2 - Human vascular endothelial cells express the urotensin-II (U-II) receptor and exhibit a strong in vitro angiogenic response to the peptide. Thus, in the present study an in vitro model, based on human umbilical vein endothelial cells (HUVEC) cultured on Matrigel, was used to characterize more in detail the signaling pathways that control the pro-angiogenic action of U-II. The activation of the U-II receptor (UT) was associated with an increase of intracellular calcium concentration. Both calcium rise and pro-angiogenic effect of the peptide can be blocked by U73122, a selective inhibitor of phospholipase-C, indicating that the signal transduction from UT mainly involves the phospholipase-C/IP3 pathway. As far as the downstream signaling pathways are concerned, western blot analyses and experiments with specific inhibitors indicated that the U-II-induced self-organization of the cells into capillary-like structures was PKC dependent and involved the activation of the ERK1/2, but not p38-MAPK, transduction pathway. Interestingly, the pharmacological inhibition of PI3K (obtained with LY294002), hindered the capacity of U-II to induce a proangiogenic effect on HUVEC, suggesting that PI3K-dependent pathways also play a role in regulating the process.

AB - Human vascular endothelial cells express the urotensin-II (U-II) receptor and exhibit a strong in vitro angiogenic response to the peptide. Thus, in the present study an in vitro model, based on human umbilical vein endothelial cells (HUVEC) cultured on Matrigel, was used to characterize more in detail the signaling pathways that control the pro-angiogenic action of U-II. The activation of the U-II receptor (UT) was associated with an increase of intracellular calcium concentration. Both calcium rise and pro-angiogenic effect of the peptide can be blocked by U73122, a selective inhibitor of phospholipase-C, indicating that the signal transduction from UT mainly involves the phospholipase-C/IP3 pathway. As far as the downstream signaling pathways are concerned, western blot analyses and experiments with specific inhibitors indicated that the U-II-induced self-organization of the cells into capillary-like structures was PKC dependent and involved the activation of the ERK1/2, but not p38-MAPK, transduction pathway. Interestingly, the pharmacological inhibition of PI3K (obtained with LY294002), hindered the capacity of U-II to induce a proangiogenic effect on HUVEC, suggesting that PI3K-dependent pathways also play a role in regulating the process.

KW - Angiogenesis

KW - Human endothelial cells

KW - Signaling pathways

KW - Urotensin-II

UR - http://www.scopus.com/inward/record.url?scp=77952673513&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77952673513&partnerID=8YFLogxK

U2 - 10.1016/j.regpep.2010.02.009

DO - 10.1016/j.regpep.2010.02.009

M3 - Article

C2 - 20171992

AN - SCOPUS:77952673513

VL - 162

SP - 26

EP - 32

JO - Regulatory Peptides

JF - Regulatory Peptides

SN - 0167-0115

IS - 1-3

ER -